Bristol Halts Study on 'Serious' Issue
Bristol-Myers has suspended its study of a drug intended to treat liver disease hepatitis C after a patient suffered heart failure
Original Article: Bristol Halts Study on 'Serious' Issue
NEXT ARTICLEBristol-Myers has suspended its study of a drug intended to treat liver disease hepatitis C after a patient suffered heart failure
Original Article: Bristol Halts Study on 'Serious' Issue
NEXT ARTICLE